Lower molecular weight intravenous iron dextran for restless legs syndrome
Authors:
- Yong Won ChoYCYong Won Cho
- Richard P. AllenRARichard P. Allen
- Christopher J. EarleyCEChristopher J. Earley
- 1 March 2013
- journal article
- clinical trial
- Published by Elsevier in Sleep Medicine
- Vol. 14 (3) , 274-277
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Intravenous iron dextran for severe refractory restless legs syndromeSleep Medicine, 2010
- Multiregional brain iron deficiency in restless legs syndromeMovement Disorders, 2008
- Is ferroportin–hepcidin signaling altered in restless legs syndrome?Journal of the Neurological Sciences, 2006
- MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndromeSleep Medicine, 2006
- CSF iron, ferritin and transferrin levels in restless legs syndromeJournal of Sleep Research, 2005
- The treatment of restless legs syndrome with intravenous iron dextranSleep Medicine, 2004
- Neuropathological examination suggests impaired brain iron acquisition in restless legs syndromeNeurology, 2003
- Restless legs syndrome: diagnostic criteria, special considerations, and epidemiologySleep Medicine, 2003
- Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndromeNeurology, 2000
- Iron and The Restless Legs SyndromeSLEEP, 1998